(HealthDay)—Obese children and adolescents treated with twice-daily metformin have significantly improved body mass index standard deviation scores (BMI-SDS), fasting glucose, and other metabolic risk factors, according ...
Dec 21, 2012
0
0
Poor eating and exercise habits could be the game-changer in the fight against heart disease and stroke deaths, according to the American Heart Association's "Heart Disease and Stroke Statistical Update 2013," published in ...
Dec 12, 2012
0
0
The University of Ottawa Heart Institute (UOHI) participated in the largest genetic study of Coronary Artery Disease (CAD) to date. Researchers from the CARDIoGRAMplusC4D Consortium report the identification of 15 genetic ...
Dec 3, 2012
0
0
A new study suggests that increasing the amount of sleep that adults get could lead to reduced food intake, but the hormonal process differs between men and women.
Oct 31, 2012
0
0
Kids born to moms who have lost a substantial amount of weight after undergoing bariatric surgery have fewer cardiovascular risk factors than their siblings who were born before the weight loss surgery.
Oct 29, 2012
0
0
High blood pressure, blood sugar, blood lipids, and body mass index—characteristics that are often lumped together as the metabolic syndrome—are jointly linked with an increased risk of dying from prostate cancer. That ...
Oct 22, 2012
0
0
Daily activities, such as fast walking and jogging, can curb the development of risk factors for heart disease and stroke by as much as 50 percent, whereas an hour's daily walk makes little difference, indicates research ...
Oct 9, 2012
0
0
(HealthDay)—People who spend a lot of time sitting are at increased risk for kidney disease, according to a new study.
Oct 3, 2012
0
0
Low levels of vitamin D and high levels of parathyroid hormone are associated with increased mortality in African American and Caucasian older adults, according to a new study accepted for publication in The Endocrine Society's ...
Oct 2, 2012
1
1
A research team led by Dr. Christos Mantzoros, MD, PhD, at Beth Israel Deaconess Medical Center, Harvard Medical School, has published new findings elucidating the molecular and clinical role of FNDC5/irisin in humans.
Oct 1, 2012
0
0
